SCHEMBL31450343

SCHEMBL31450343

O=C(O)c1cncc(-c2cc(F)cc(F)c2)c1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HCAR2 Q8TDS4 5/20 0.63
▸ MKNK1 Q9BUB5 1/20 0.56
▸ MKNK2 Q9HBH9 1/20 0.56
▸ KDM4E B2RXH2 3/20 0.48
▸ ALDH1A1 P00352 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ POLB P06746 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ DDO Q99489 1/20 0.48
▸ XDH P47989 1/20 0.44
▸ LDHA P00338 1/20 0.42
▸ SCN10A Q9Y5Y9 1/20 0.41
▸ HCAR1 Q9BXC0 1/20 0.41
▸ SCD O00767 1/20 0.41
▸ KMO O15229 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ ABL1 P00519 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31418220 0.90 HCAR2 (0.56) HCAR2MKNK1MKNK2KDM4EALDH1A1
SCHEMBL3181717 0.86 MKNK1 (0.69) HCAR2MKNK1MKNK2KDM4EALDH1A1
SCHEMBL28498113 0.85 HCAR2 (0.63) HCAR2MKNK1MKNK2KDM4EALDH1A1
SCHEMBL28134052 0.84 MKNK1 (0.62) HCAR2MKNK1MKNK2KDM4EALDH1A1
SCHEMBL31242967 0.84 CYP11B2 (0.55) HCAR2MKNK1MKNK2SCN10AABL1
SCHEMBL2900222 0.84 MKNK1 (0.68) HCAR2MKNK1MKNK2KDM4EALDH1A1
SCHEMBL27987797 0.84 CYP11B2 (0.55) HCAR2MKNK1MKNK2SCN10AABL1
SCHEMBL31475536 0.83 HCAR2 (0.56) HCAR2MKNK1MKNK2KMO
SCHEMBL25544943 0.83 HCAR2 (0.56) HCAR2MKNK1MKNK2KMO
SCHEMBL7079108 0.80 HCAR2 (0.52) HCAR2MKNK1MKNK2LDHAHCAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743464-A1 SOMATOSTATIN SUBTYPE RECEPTOR 3 (SSTR3) AGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2026-05-20 — — EP disclosed
WO-2025019256-A1 SOMATOSTATIN SUBTYPE RECEPTOR 3 (SSTR3) AGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2025-01-23 — — WO disclosed
Send feedback